<DOC>
	<DOCNO>NCT03022630</DOCNO>
	<brief_summary>The purpose study evaluate , randomize control trial , impact integrate comprehensive palliative care service time first hospital readmission hospital utilization outcome , quality life , patient/caregiver outcomes . The intervention include comprehensive , standardized palliative care service adult hepatology patient prognosis poor .</brief_summary>
	<brief_title>Palliative Care Non-Malignant Diseases ( COMPASS Trial )</brief_title>
	<detailed_description>Palliative care specialize medical care focus provide patient relief symptom , pain , stress serious life-limiting illness , regardless diagnosis , anticipate , prevent , treat suffering . Palliative care aim provide patient family service help patient make best possible medical decision face serious illness . Unfortunately often think synonymous hospice care therefore underutilized part standard care . Patients chronic liver disease cirrhosis may particularly underserved population palliative care , palliative care may disregard hope liver transplantation lose . Study Description : - Adult patient admit Vanderbilt University Medical Center advance liver disease poor prognosis randomize receive either usual hepatic care usual hepatic care comprehensive palliative care service . - Participants randomize intervention arm receive patient-friendly informational material , comprehensive initial palliative care consultation , follow-up consultation inpatient . After discharge hospital , follow-up consults occur via telephone contact . Telephone contact occur flexible schedule base need wish participant minimum frequency one contact per month . - Participants receive palliative care intervention least 1 year randomization intervention arm death . - Participants randomize usual care arm schedule meet palliative care service unless meet requested patient , family , treat physician . These consultation include palliative care service intervention arm , exclude telephone follow-up consultation . - All participant complete quality life , mood , satisfaction care assessment specify time point 1 year randomization death . Optional caregiver participation include completion satisfaction care assessment . Specific aim include : 1 . Assess impact systematic , comprehensive palliative care service compare usual hepatic care time first hospital readmission within 1-year post randomization . 2 . Assess impact systematic , comprehensive palliative care service compare usual hepatic care hospital utilization , include day alive hospital within 6- month post randomization , total day hospital ( ICU ) within 1-year post randomization , number cost hospital admission within 1-year post randomization , median length stay per admission , transfer time hospice placement , survival within 1-year post randomization . 3 . Assess impact systematic , comprehensive palliative care service compare usual hepatic care qualify life . 4 . Assess impact systematic , comprehensive palliative care service compare usual hepatic care patient/caregiver satisfaction . 5 . Evaluate fidelity palliative care intervention ass generalizability implement large-scale Palliative Care program .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Inpatient Vanderbilt University Medical Center advance liver disease , whose treat hepatologist indicate 'No ' response question , `` Would surprise patient die within 1 year ? '' Age &lt; 18 year Inability give write informed consent ( patient surrogate decisionmaker ) Inability respond question English Treating hepatologist denies permission enroll Receiving hepatology care nonVanderbilt site ( ensure appropriate followup )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>palliative care</keyword>
	<keyword>cirrhosis</keyword>
	<keyword>liver disease</keyword>
	<keyword>hepatology</keyword>
	<keyword>end life care</keyword>
	<keyword>supportive care</keyword>
</DOC>